This marks Marius Pharmaceuticals’ fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company’s ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

StockNews.com started coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a report issued on Tuesday ...

Credit: PeopleImages.com – Yuri A/Shutterstock. TC BioPharm (TCBP) has signed a non-binding letter of intent (LoI) to acquire an ophthalmic pharmaceutical company focused on commercialising ...

According to GlobalData’s Pharma Intelligence Center, dordaviprone is forecast to generate up to $385m in global sales by 2030. GlobalData is the parent company of Pharmaceutical Technology. The ...

Department of Chemical Engineering and Environmental Technology, University of Valladolid, Dr. Mergelina s/n., 47011 Valladolid, Spain Institute of Sustainable Processes, University of Valladolid, Dr.

abrdn plc raised its holdings in Marinus Pharmaceuticals by 146.1% in the third quarter. abrdn plc now owns 2,658,527 shares of the biopharmaceutical company’s stock worth $4,679,000 after ...

(RTTNews) - Eli Lilly and Company (LLY) Wednesday announced plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in ...